10-K: 22nd Century Group Faces Going Concern Doubt Amid Losses

22nd Century Group reported significant losses and negative cash flow for 2025, raising substantial doubt about its ability to continue as a going concern, despite strategic advancements in its reduced nicotine content tobacco products and a recent capital raise.

Summary

• The company incurred a net loss of $5.054 million for the full year 2025, an improvement from $15.164 million in 2024.
• Net revenues for the full year 2025 decreased by 27.9% to $17.587 million from $24.382 million in 2024.
• Gross loss increased to $3.137 million in 2025 from $2.400 million in 2024, primarily due to a shift in product mix.
• Operating loss from continuing operations improved to $11.566 million in 2025 from $13.950 million in 2024.
• Cash and cash equivalents increased to $7.149 million as of December 31, 2025, from $4.422 million in 2024.
• Working capital from continuing operations improved significantly to $10.359 million in 2025 from $1.790 million in 2024.
• The company completed a Series B Convertible Preferred Stock offering in March 2026, raising $16 million initially, used to repurchase all outstanding Series A Preferred Stock.
• Substantial doubt exists regarding the company's ability to continue as a going concern due to a history of losses and negative cash flows.
• The company continues to commercialize its FDA-authorized VLN® reduced nicotine content cigarettes and is expanding distribution.
• A Master Services Agreement was signed with Smoker Friendly, covering 11 existing brands and 8 new premium brands, and another with Murphy Oil USA for the Pinnacle private label brand, including moist snuff.
• The company settled insurance litigation for $9.5 million related to a 2022 fire at its Grass Valley manufacturing facility.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging financial report, primarily due to the explicit 'going concern' warning and significant revenue decline. While strategic initiatives and a recent capital raise offer some hope, the underlying financial health remains precarious.

Positives

• Net loss significantly improved to $5.054 million in 2025 from $15.164 million in 2024.
• Operating loss from continuing operations improved by 17.1% to $11.566 million in 2025.
• Cash and cash equivalents increased to $7.149 million as of December 31, 2025, from $4.422 million in 2024.
• Working capital from continuing operations improved by $8.569 million to $10.359 million in 2025.
• Successful settlement of insurance litigation for $9.5 million in October 2025, related to the Grass Valley fire.
• Secured new licensing and manufacturing agreements with Smoker Friendly and expanded the Pinnacle private label brand with Murphy Oil USA, leveraging contract manufacturing relationships for growth.
• VLN® cigarettes, the only FDA-authorized combustible tobacco products with minimally or non-addictive nicotine levels, are expanding national distribution.
• A 2024 study showed over 40% of low nicotine cigarette users reduced consumption, validating the VLN® product concept.
• The company reapplied to the FDA in 2025 to extend the exposure modification order for VLN® cigarettes beyond December 23, 2026.
• Redeemed all 9,650 shares of Series A preferred stock using proceeds from the Series B offering, simplifying the capital structure.

Negatives

• The company has a history of significant losses and negative cash flows from operations since inception.
• Substantial doubt exists regarding the company's ability to continue as a going concern.
• Net revenues for the full year 2025 decreased by 27.9% to $17.587 million compared to $24.382 million in 2024.
• Gross loss increased by 30.7% to $3.137 million in 2025 from $2.400 million in 2024, primarily due to product mix shift.
• Cigarette sales net revenues decreased in 2025 due to pricing arrangements recorded as consideration payable to the customer.
• Filtered cigars net revenues decreased by $5.317 million in 2025 due to lower volumes and repricing of customer contracts.
• The company's adjusted EBITDA loss for fiscal year 2025 resulted in a $0 payout for performance-based cash bonuses to executive officers.
• The company continues to face intense competition from larger tobacco and pharmaceutical companies with greater resources and brand recognition.
• The stock price has been highly volatile and could decline in value, with risks of short squeezes and dilution from future sales.

Risks

• History of losses and expected continuing losses, raising substantial doubt about the ability to continue as a going concern.
• Need for additional funding to execute business plans and continue operations; no assurance of raising necessary capital.
• Competitors generally have greater financial resources, brand recognition, and may develop superior products or technologies.
• Research and development process may not develop marketable products cost-effectively or at all.
• Potential unsuccessfulness in commercializing RNC tobacco and VLN® brand cigarettes.
• Significant government regulation in tobacco manufacturing, with failure to comply leading to adverse effects and fines.
• Potential for litigation related to cigarette smoking and/or exposure to environmental tobacco smoke.
• Loss of a significant contract manufacturing customer could adversely impact results of operations.
• Tobacco is an agricultural product subject to conditions affecting annual harvest, limiting product sales ability.
• Product liability claims, product recalls, or other claims could cause losses or damage reputation.
• FDA could force removal of products from the U.S. market, including non-renewal of MRTP orders for VLN® cigarettes.
• States or National Association of Attorneys General (NAAG) may not approve products in certain states.
• Expiration or inadequate protection of proprietary intellectual property rights.
• Reliance on third-party patent licenses; if owners fail to maintain or enforce, competitive position could be harmed.
• Failure of information systems or cybersecurity breaches could result in business disruption, litigation, and loss of data.
• Inability to remain listed on the NASDAQ stock market.
• Stock price may be highly volatile and could decline in value.
• Future sales of common stock will result in dilution to common stockholders.
• No expectation to declare dividends on common stock in the foreseeable future.
• Common stock may become the target of a short squeeze.
• Anti-takeover provisions in corporate documents and Nevada law could impair takeover attempts.
• Limited experience marketing and selling Modified Exposure Cigarettes, leading to potential incorrect working capital and inventory estimates.
• Extended disruption at the North Carolina manufacturing facility or in service by a supplier/distributor.
• A ban on menthol or flavored tobacco products could materially impact the business.

Future Outlook

The company plans to continue expanding national distribution of its VLN® cigarettes in 2026, targeting the approximately 270,000 domestic tobacco retail outlets and a meaningful share of the $58 billion combustible cigarette market in the U.S. It aims to build a 'House of Brands' for RNC tobacco products, leveraging contract manufacturing relationships for integrative volume growth and enhanced retail access. The company also expects to develop new versions of RNC cigarettes using cutting-edge non-GMO bioengineering technologies for future commercialization globally, including an American blend. The FDA's proposed rule mandating substantially reduced nicotine content in all combusted tobacco products, if approved, is seen as a potential benefit for the company, which has the only FDA-authorized combustible cigarette able to meet the proposed standard. The company is actively pursuing financing strategies, including additional securities issuance and strategic partnerships, to address its going concern doubt.

Management Comments

• "The Company remains dedicated to being the leader of the tobacco harm reduction movement through science-based innovation, regulatory alignment, and responsible commercialization of reduced nicotine content combustibles."
• "Our mission is to provide adult smokers with alternatives in the form factor that they are comfortable with, cigarettes, that significantly reduce nicotine exposure, supporting the potential for reduced dependence while preserving consumer choice."
• "We expect this House of Brands to drive retail shelf visibility, consumer recognition, and overall volume expansion."
• "Our goal is to release what we see as the enormous untapped value of a disruptive product alternative capable of fulfilling unmet demand within a nearly $58 billion market segment that includes adult smokers who have already declared the need or want to change their smoking habit."
• "Managements plans do not alleviate substantial doubt about the Companys ability to continue as a going concern through one year following the date that the Consolidated Financial Statements are issued."

Industry Context

StockSavvy.ai notes that 22nd Century Group operates in a highly regulated and competitive tobacco industry, uniquely positioned by its FDA-authorized Modified Risk Tobacco Products (MRTP) for reduced nicotine content (RNC) cigarettes. The company's strategy to build an 'RNC category' of products, including partner brands, aligns with a potential future where FDA mandates lower nicotine levels across all combustible tobacco products, as indicated by the January 2025 NPRM. This positions 22nd Century Group as a potential first-mover and leader in a disruptive segment, akin to the growth of zeroand low-proof spirits. However, the industry is dominated by major players like Philip Morris USA Inc., Reynolds American Inc., and British American Tobacco, which possess significantly greater financial, R&D, and distribution resources, posing substantial competitive challenges. The company's contract manufacturing business also places it in direct competition with established brands while simultaneously offering a channel for its RNC products.

Comparison to Industry Standards

• 22nd Century Group's VLN® cigarettes are the only combustible tobacco products with Modified Risk Tobacco Product (MRTP) designation from the FDA, setting them apart from conventional cigarettes offered by competitors like Philip Morris USA Inc. and Reynolds American Inc.
• The company's RNC tobacco technology, enabling 95% less nicotine, is a unique offering compared to traditional tobacco products, which typically contain addictive levels of nicotine.
• A 2024 marketplace research study using the company's Spectrum research cigarettes, showing over 40% of users reduced consumption, provides a strong scientific basis for its products, a claim not typically made or authorized for conventional cigarettes.
• The company's strategy to build an 'RNC category' with tiers of proprietary and partner brands aims to disrupt the market similar to how the zeroand low-proof spirits segment (e.g., Seedlip, Lyre's) has grown into a multi-billion-dollar market by offering alternatives to traditional alcoholic beverages, rather than directly competing on the same terms.
• In the market for FDA-approved smoking cessation aids, 22nd Century Group's RNC products compete indirectly with pharmaceutical companies like Pfizer Inc. (Chantix) and GlaxoSmithKline plc (Nicorette), offering a different approach to nicotine reduction within the combustible tobacco format.

Management Changes

Corporate Governance

Legal Proceedings

• Shareholder Derivative Cases: A shareholder derivative claim filed in February 2019 was fully resolved and finally approved on July 16, 2025. The settlement included corporate governance reforms and $768,000 for plaintiff's attorney and legal fees, fully covered by insurance.
• Insurance Litigation: A complaint filed against Dorchester Insurance Company, Ltd. in July 2023 regarding a November 2022 fire at the Grass Valley facility was fully resolved for $9.5 million via a Settlement Agreement and Release executed on September 18, 2025. Payment was received on October 29, 2025.
• KeyGene Dispute: A Request for Arbitration from Keygene N.V. in April 2024 was fully resolved pursuant to a Settlement Agreement and Mutual Release executed on April 25, 2025.
• Cookies Retail Products Dispute: An ongoing complaint filed in October 2024 alleging breach of contract, fraud, and violation of penal code. The court granted the company's motion to strike two of the three counts in April 2025. Discovery is ongoing, with a trial date set for October 27, 2026.
• Employee Dispute: An ongoing complaint filed in November 2024 by a former employee alleging premises liability, personal injury, and negligence related to the November 2022 Grass Valley fire. The company has moved to dismiss all counts and intends to defend itself vigorously.

Related Party Transactions

• The company generated revenue from a related party contract manufacturing customer in Q4 2024 and during 2025, but the private label cigarette revenue and corresponding contract asset were not material. This arrangement was terminated in April 2025.

Stakeholder Impact

• Shareholders: Face substantial doubt about the company's ability to continue as a going concern, significant dilution risk from past and future equity raises, and potential stock price volatility. The recent capital raise and debt repayment offer short-term stability but long-term profitability remains a challenge.
• Employees: Headcount reduction occurred in 2025 as part of cost-cutting initiatives. The company aims to attract and retain highly motivated employees through competitive compensation and a flexible/safe work environment.
• Customers (Contract Manufacturing): New agreements with Smoker Friendly and Murphy Oil USA indicate continued business, but repricing of contracts and shifts in product mix may affect relationships and volumes.
• Customers (VLN®): The expansion of VLN® products offers adult smokers a choice in nicotine consumption, potentially benefiting public health if the products gain wider acceptance.
• Creditors: The full repayment of the Senior Secured Credit Facility and redemption of Series A Preferred Stock improve the balance sheet and reduce immediate debt obligations, but the going concern warning indicates ongoing risk.

Next Steps

• Expand national distribution of VLN® cigarettes in 2026.
• Continue to build a 'House of Brands' for RNC tobacco products.
• Develop new versions of RNC cigarettes utilizing cutting-edge non-GMO bioengineering technologies for future commercialization in the U.S. and globally.
• Reapply to the FDA to extend the exposure modification order for VLN® cigarettes beyond December 23, 2026.
• Continue evaluating strategies for reducing expenses and pursuing financing strategies, including additional funds through securities issuance, asset sales, and strategic partners.
• Monitor the ongoing Cookies Retail Products dispute, with a trial date set for October 27, 2026.
• Monitor the ongoing former employee dispute related to the Grass Valley fire.

Key Dates

Recommendation

The company's financial performance, marked by significant losses and a 'going concern' warning, presents a high-risk profile. While the recent capital raise and strategic focus on FDA-authorized reduced nicotine content products offer a potential long-term growth vector and some operational improvements are noted, the immediate financial instability and competitive pressures warrant caution. A 'hold' recommendation reflects the speculative nature of the investment, acknowledging the potential upside from its unique product positioning and market expansion efforts, balanced against the severe financial risks and uncertainty about achieving sustained profitability.

Keywords

Reduced Nicotine Content, VLN cigarettes, SEC 10-K, Tobacco Harm Reduction, FDA MRTP, Going Concern, Capital Raise, Contract Manufacturing, Tobacco Industry, Financial Performance, Corporate Governance, Intellectual Property, Litigation, Nasdaq